Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-058292

Chief Executive Officer sold 4,400 shares at an average $13.59 ($59,774)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-10-26 Sale −2,200 $13.57 $29,854 426,378 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-10-27 Sale −2,200 $13.60 $29,920 424,178 I: show line 2 in the form
Open-market sales · 4,400 sh · avg $13.59 · $59,774
Loading xslF345X03/doc4.xml…